$AMRN

$11.85 +$0.06 (0.51%) Live

$AMRN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AMRN Management Team

Mr. Jonathan Provoost

Executive Vice President

Chief Legal and Compliance Officer

Secretary

Age 55

Compensation $701.8K USD

Sex Male

Dr. Odysseas Kostas

Non-Executive Independent Chairman of the Board

Age 50

Compensation $240.1K USD

Sex Male

Mr. Aaron Berg

President

Chief Executive Officer

Director

Age 62

Compensation $3.277M USD

Sex Male

Mr. Peter Fishman

Chief Financial Officer

Age 41

Compensation $606.0K USD

Sex Male

Dr. Stephen Ketchum

President - Research and Development

Executive Vice President

Chief Scientific Officer

Age 60

Compensation $1.733M USD

Sex Male

Dr. David Keenan

Chief Operating Officer

Executive Vice President

Age 58

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Jonathan Provoost Executive Vice President Chief Legal and Compliance Officer Secretary	55	$701.8K USD	Male
Dr. Odysseas Kostas Non-Executive Independent Chairman of the Board	50	$240.1K USD	Male
Mr. Aaron Berg President Chief Executive Officer Director	62	$3.277M USD	Male
Mr. Peter Fishman Chief Financial Officer	41	$606.0K USD	Male
Dr. Stephen Ketchum President - Research and Development Executive Vice President Chief Scientific Officer	60	$1.733M USD	Male
Dr. David Keenan Chief Operating Officer Executive Vice President	58	-	Male

Board of Directors

From the proxy statement filed Apr 10, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

2.7 years

from year joined

CEO also chairs the board

Odysseas Kostas, M.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Aaron D. Berg CEO	63	2024 2 years	Not independent	None stated	None stated	Paid as CEO
Patrice Bonfiglio	43	2023 3 years	Independent	None stated	None stated	$63,089
Keith L. Horn	67	2023 3 years	Independent	None stated	None stated	$71,903
Odysseas Kostas, M.D. Board chair	51	2023 3 years	Independent	None stated	Armata Pharmaceuticals, Inc.	$73,577
Louis Sterling III	47	2023 3 years	Independent	None stated	None stated	$67,532
Diane E. Sullivan	64	2023 3 years	Independent	None stated	Lexicon Pharmaceuticals, Inc.	$68,842
Michael Torok	47	2025 1 year	Independent	None stated	Liberated Syndication, Inc.	$31,189
Paul Cohen, M.D. Leaving at the meeting	51	2023 3 years	Independent	None stated	None stated	$54,711
Oliver O'Connor Leaving at the meeting	64	2023 3 years	Independent	None stated	None stated	$32,883

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$AMRN Management Team

Mr. Jonathan Provoost

Dr. Odysseas Kostas

Mr. Aaron Berg

Mr. Peter Fishman

Dr. Stephen Ketchum

Dr. David Keenan

Board of Directors

Related-party transactions

No related-party transactions disclosed